8-47962049-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182746.3(MCM4):c.236-4A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00336 in 1,613,306 control chromosomes in the GnomAD database, including 283 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_182746.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCM4 | NM_182746.3 | c.236-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000649973.1 | NP_877423.1 | |||
MCM4 | NM_005914.4 | c.236-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_005905.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCM4 | ENST00000649973.1 | c.236-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NM_182746.3 | ENSP00000496964 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00478 AC: 727AN: 152172Hom.: 44 Cov.: 33
GnomAD3 exomes AF: 0.00994 AC: 2486AN: 249976Hom.: 151 AF XY: 0.00920 AC XY: 1245AN XY: 135392
GnomAD4 exome AF: 0.00321 AC: 4696AN: 1461016Hom.: 238 Cov.: 32 AF XY: 0.00323 AC XY: 2344AN XY: 726800
GnomAD4 genome AF: 0.00477 AC: 727AN: 152290Hom.: 45 Cov.: 33 AF XY: 0.00537 AC XY: 400AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at